Filter
1814
Filtered Results: 1814
Text search:
vaccine
doses
Featured
Recommendations
195
New Publications
483
Language
Document type
No document type
833
Studies & Reports
308
Guidelines
305
Strategic & Response Plan
98
Fact sheets
88
Manuals
85
Situation Updates
43
Training Material
23
Infographics
12
Resource Platforms
11
Brochures
4
Videos
3
App
1
Countries / Regions
India
94
Global
71
Congo, Democratic Republic of
48
South Africa
44
Kenya
43
Brazil
36
Latin America and the Carribbean
35
Senegal
33
Africa
33
Ethiopia
33
Nigeria
32
Uganda
31
Haiti
27
Nepal
24
Ghana
23
Sierra Leone
23
Tanzania
23
Bangladesh
22
Zambia
22
Philippines
20
Western and Central Europe
20
Rwanda
19
Malawi
19
Liberia
19
Cameroon
17
Zimbabwe
17
West and Central Africa
17
East and Southern Africa
17
Syria
16
Benin
14
Namibia
14
Ukraine
13
South Sudan
12
Burkina Faso
11
South–East Asia Region
11
Lesotho
10
Guinea
10
Middle East and North Africa
10
Pakistan
10
Venezuela
9
Mozambique
8
Cambodia
8
Mali
8
Myanmar / Burma
8
Niger
7
Eastern Europe
7
Yemen
7
Angola
7
Indonesia
7
Colombia
6
Afghanistan
6
Lebanon
6
Central African Republic
6
Madagascar
6
Guinea-Bissau
5
Germany
5
Eastern Europe and Central Asia
5
Chad
5
Botswana
5
Chile
4
Côte d’Ivoire / Ivory Coast
4
Argentina
4
Somalia
4
Peru
3
Asia
3
Western Pacific Region
3
Russia
3
Sudan
3
Eswatini/ Swaziland
3
El Salvador
2
Togo
2
Congo-Brazzaville
2
Burundi
2
Morocco
2
Saudi Arabia
2
Paraguay
2
Bolivia
2
Papua New Guinea
2
Moldova
2
Palestine
2
Libya
2
Iraq
2
North Macedonia
1
Tajikistan
1
Gambia
1
Iran
1
Laos
1
Qatar
1
Bulgaria
1
Jordan
1
North America
1
Denmark
1
France
1
Tunisia
1
United Kingdom
1
Sri Lanka
1
Djibouti
1
Egypt
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
793
Clinical Guidelines
240
Women & Child Health
122
Public Health
82
Key Resources
50
Capacity Building
15
Pharmacy & Technologies
14
Annual Report MEDBOX
1
Toolboxes
COVID-19
330
Rapid Response
96
AMR
82
HIV
62
TB
62
Ebola & Marburg
51
Pharmacy
49
Polio
49
Cholera
48
NTDs
47
Caregiver
36
Conflict
32
Refugee
29
Planetary Health
24
Mental Health
17
Global Health Education
17
Health Financing Toolbox
15
NCDs
13
Natural Hazards
11
Zika
8
Specific Hazards
7
Disability
2
Malaria
2
Many countries are using the approach of mixing vaccine doses from different manufacturers. What do we know about the safety and efficacy of this approach? What does the evidence tell us about using a fraction of the vaccine dose ? Dr Katherine O’Brien explains in Science in 5 this week.
Closed C...
September 2021
26 March 2021
If you have already had COVID-19 do you still need both doses of the vaccine? Do these vaccines protect you against infection? Do they protect us against variants? WHO’s Dr Katherine O’Brien answers these questions in Science in 5 this week.
To survive and thrive from early childhood through to adolescence and beyond, children need to be healthy. This enables them to access education so that every child in Ukraine, irrespective of background or circumstance, has an equal chance to fulfill their potential.
To ensure children thrive and ...
This article describes WHO's efforts to combat a cholera outbreak in South Sudan in July 2017. The organization received 500,000 doses of oral cholera vaccine (OCV) and was working with South Sudan's Ministry of Health to launch a vaccination campaign from July 28 to August 3, 2017. At the time, the...
A regimen of four 1-mL doses of HDCV or PCEC vaccines should be administered intramuscularly to previously unvaccinated persons.
The first dose of the four-dose course should be administered as soon as possible after exposure. Additional doses should be administered on days 3, 7, and 14 after the...
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the COVID-19 Vaccine BIBP/ Sinopharm, th...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
This report provides an overview of the progress in the roll-out of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA Member States. It presents the number of vaccine doses distributed by manufacturers to each Member State for the different approved vaccines and the number of first...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
